Pebblebrook Hotel Trust has a consensus price target of $23.06 based on the ratings of 15 analysts. The high is $125 issued by Barclays on July 5, 2023. The low is $11 issued by Evercore ISI Group on April 28, 2025. The 3 most-recent analyst ratings were released by Evercore ISI Group, Stifel, and Wells Fargo on April 28, 2025, April 16, 2025, and February 18, 2025, respectively. With an average price target of $12.42 between Evercore ISI Group, Stifel, and Wells Fargo, there's an implied 37.96% upside for Pebblebrook Hotel Trust from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/28/2025 | Buy Now | 22.22% | Evercore ISI Group | Richard Hightower51% | $15 → $11 | Maintains | In-Line | Get Alert |
04/16/2025 | Buy Now | 47.22% | Stifel | Simon Yarmak61% | $16.5 → $13.25 | Maintains | Buy | Get Alert |
03/10/2025 | Buy Now | — | Compass Point | Floris Van Dijkum57% | — | Downgrade | Buy → Neutral | Get Alert |
02/18/2025 | Buy Now | 44.44% | Wells Fargo | Dori Kesten55% | $16 → $13 | Maintains | Equal-Weight | Get Alert |
02/04/2025 | Buy Now | 44.44% | Truist Securities | Gregory Miller65% | $14 → $13 | Maintains | Hold | Get Alert |
12/09/2024 | Buy Now | 77.78% | Wells Fargo | Dori Kesten55% | $14 → $16 | Maintains | Equal-Weight | Get Alert |
11/26/2024 | Buy Now | 55.56% | Wells Fargo | Dori Kesten55% | $13 → $14 | Maintains | Equal-Weight | Get Alert |
11/22/2024 | Buy Now | 66.67% | Stifel | Simon Yarmak61% | $14.75 → $15 | Upgrade | Hold → Buy | Get Alert |
11/21/2024 | Buy Now | 88.89% | Compass Point | Floris Van Dijkum57% | $17 → $17 | Upgrade | Neutral → Buy | Get Alert |
11/08/2024 | Buy Now | 58.33% | Stifel | Simon Yarmak61% | $14.75 → $14.25 | Maintains | Hold | Get Alert |
11/04/2024 | Buy Now | 58.33% | Stifel | Simon Yarmak61% | $16 → $14.25 | Maintains | Hold | Get Alert |
10/31/2024 | Buy Now | 55.56% | Baird | Michael Bellisario54% | $15 → $14 | Maintains | Neutral | Get Alert |
10/28/2024 | Buy Now | 55.56% | Truist Securities | Gregory Miller65% | $15 → $14 | Maintains | Hold | Get Alert |
09/13/2024 | Buy Now | 44.44% | Wells Fargo | Dori Kesten55% | $15 → $13 | Maintains | Equal-Weight | Get Alert |
05/30/2024 | Buy Now | 66.67% | Truist Securities | Gregory Miller65% | $16 → $15 | Maintains | Hold | Get Alert |
03/28/2024 | Buy Now | 88.89% | Compass Point | Floris Van Dijkum57% | $28 → $17 | Downgrade | Buy → Neutral | Get Alert |
02/22/2024 | Buy Now | 94.44% | Stifel | Simon Yarmak61% | $16.5 → $17.5 | Maintains | Hold | Get Alert |
01/18/2024 | Buy Now | 77.78% | Truist Securities | Gregory Miller65% | $15 → $16 | Maintains | Hold | Get Alert |
01/12/2024 | Buy Now | 66.67% | Baird | Michael Bellisario54% | $14 → $15 | Maintains | Neutral | Get Alert |
01/08/2024 | Buy Now | 50% | B of A Securities | Shaun Kelley57% | → $13.5 | Downgrade | Neutral → Underperform | Get Alert |
12/22/2023 | Buy Now | 77.78% | Wells Fargo | Dori Kesten55% | $14 → $16 | Maintains | Equal-Weight | Get Alert |
12/08/2023 | Buy Now | 55.56% | Wells Fargo | Dori Kesten55% | $13 → $14 | Maintains | Equal-Weight | Get Alert |
11/13/2023 | Buy Now | 44.44% | Wells Fargo | Dori Kesten55% | $16 → $13 | Maintains | Equal-Weight | Get Alert |
11/07/2023 | Buy Now | 22.22% | Morgan Stanley | Stephen Grambling62% | $12 → $11 | Maintains | Underweight | Get Alert |
10/30/2023 | Buy Now | 55.56% | Baird | Michael Bellisario54% | $16 → $14 | Maintains | Neutral | Get Alert |
10/19/2023 | Buy Now | 66.67% | Truist Securities | Gregory Miller65% | $16 → $15 | Maintains | Hold | Get Alert |
10/16/2023 | Buy Now | 33.33% | Morgan Stanley | Stephen Grambling62% | $11 → $12 | Maintains | Underweight | Get Alert |
10/03/2023 | Buy Now | 55.56% | Wedbush | Richard Anderson62% | → $14 | Initiates | → Neutral | Get Alert |
09/28/2023 | Buy Now | — | Wolfe Research | Keegan Carl61% | — | Initiates | → Peer Perform | Get Alert |
09/22/2023 | Buy Now | 77.78% | Truist Securities | Gregory Miller65% | $16 → $16 | Reiterates | Hold → Hold | Get Alert |
08/25/2023 | Buy Now | 22.22% | Morgan Stanley | Stephen Grambling62% | $12 → $11 | Maintains | Underweight | Get Alert |
07/31/2023 | Buy Now | 77.78% | Wells Fargo | Dori Kesten55% | $15 → $16 | Maintains | Equal-Weight | Get Alert |
07/31/2023 | Buy Now | 77.78% | Baird | Michael Bellisario54% | $14 → $16 | Maintains | Neutral | Get Alert |
07/14/2023 | Buy Now | 66.67% | Citigroup | Smedes Rose37% | $16.5 → $15 | Maintains | Neutral | Get Alert |
07/12/2023 | Buy Now | 66.67% | Wells Fargo | Dori Kesten55% | $14.5 → $15 | Maintains | Equal-Weight | Get Alert |
07/10/2023 | Buy Now | 77.78% | Truist Securities | Patrick Scholes63% | → $16 | Reiterates | Hold → Hold | Get Alert |
07/05/2023 | Buy Now | 1288.89% | Barclays | Anthony Powell52% | $135 → $125 | Maintains | Equal-Weight | Get Alert |
06/27/2023 | Buy Now | 33.33% | Morgan Stanley | Stephen Grambling62% | $13 → $12 | Maintains | Underweight | Get Alert |
06/26/2023 | Buy Now | 55.56% | Baird | Michael Bellisario54% | $15 → $14 | Maintains | Neutral | Get Alert |
05/04/2023 | Buy Now | 61.11% | Wells Fargo | Dori Kesten55% | $14 → $14.5 | Maintains | Equal-Weight | Get Alert |
05/01/2023 | Buy Now | 44.44% | Morgan Stanley | Stephen Grambling62% | $12 → $13 | Maintains | Underweight | Get Alert |
04/27/2023 | Buy Now | 72.22% | Stifel | Simon Yarmak61% | $15.25 → $15.5 | Maintains | Hold | Get Alert |
04/26/2023 | Buy Now | 77.78% | Barclays | Anthony Powell52% | $18 → $16 | Maintains | Equal-Weight | Get Alert |
04/13/2023 | Buy Now | 77.78% | Truist Securities | Patrick Scholes63% | $18 → $16 | Maintains | Hold | Get Alert |
03/30/2023 | Buy Now | 55.56% | Wells Fargo | Dori Kesten55% | $17 → $14 | Maintains | Equal-Weight | Get Alert |
03/27/2023 | Buy Now | 69.44% | Stifel | Simon Yarmak61% | $16.5 → $15.25 | Maintains | Hold | Get Alert |
02/07/2023 | Buy Now | 33.33% | Morgan Stanley | Stephen Grambling62% | $13 → $12 | Maintains | Underweight | Get Alert |
02/02/2023 | Buy Now | 88.89% | Wells Fargo | Dori Kesten55% | $18 → $17 | Maintains | Equal-Weight | Get Alert |
02/01/2023 | Buy Now | 83.33% | Citigroup | Smedes Rose37% | $15 → $16.5 | Maintains | Neutral | Get Alert |
01/18/2023 | Buy Now | 44.44% | Morgan Stanley | Stephen Grambling62% | $15 → $13 | Maintains | Underweight | Get Alert |
12/21/2022 | Buy Now | 100% | Barclays | Anthony Powell52% | $22 → $18 | Maintains | Equal-Weight | Get Alert |
12/09/2022 | Buy Now | — | Raymond James | William Crow73% | — | Downgrade | Outperform → Market Perform | Get Alert |
12/05/2022 | Buy Now | 66.67% | Morgan Stanley | Stephen Grambling62% | → $15 | Initiates | → Underweight | Get Alert |
12/02/2022 | Buy Now | 100% | BMO Capital | Ari Klein42% | $20 → $18 | Downgrade | Outperform → Market Perform | Get Alert |
11/01/2022 | Buy Now | 144.44% | Raymond James | William Crow73% | $24 → $22 | Maintains | Outperform | Get Alert |
10/31/2022 | Buy Now | 211.11% | Compass Point | Floris Van Dijkum57% | $33 → $28 | Maintains | Buy | Get Alert |
10/31/2022 | Buy Now | 133.33% | Baird | Michael Bellisario54% | $23 → $21 | Maintains | Neutral | Get Alert |
10/20/2022 | Buy Now | 100% | Truist Securities | Patrick Scholes63% | $24 → $18 | Maintains | Hold | Get Alert |
08/29/2022 | Buy Now | 122.22% | Wells Fargo | Dori Kesten55% | → $20 | Downgrade | Overweight → Equal-Weight | Get Alert |
07/07/2022 | Buy Now | 144.44% | Barclays | Anthony Powell52% | $26 → $22 | Maintains | Equal-Weight | Get Alert |
The latest price target for Pebblebrook Hotel (NYSE:PEB) was reported by Evercore ISI Group on April 28, 2025. The analyst firm set a price target for $11.00 expecting PEB to rise to within 12 months (a possible 22.22% upside). 15 analyst firms have reported ratings in the last year.
The latest analyst rating for Pebblebrook Hotel (NYSE:PEB) was provided by Evercore ISI Group, and Pebblebrook Hotel maintained their in-line rating.
The last upgrade for Pebblebrook Hotel Trust happened on November 22, 2024 when Stifel raised their price target to $15. Stifel previously had a hold for Pebblebrook Hotel Trust.
The last downgrade for Pebblebrook Hotel Trust happened on March 10, 2025 when Compass Point changed their price target from N/A to N/A for Pebblebrook Hotel Trust.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pebblebrook Hotel, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pebblebrook Hotel was filed on April 28, 2025 so you should expect the next rating to be made available sometime around April 28, 2026.
While ratings are subjective and will change, the latest Pebblebrook Hotel (PEB) rating was a maintained with a price target of $15.00 to $11.00. The current price Pebblebrook Hotel (PEB) is trading at is $9.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.